Remote Work
Virtual Collaboration Won’t Be the Death of Creativity
Collaborating remotely can improve creativity in ways that many teams didn’t realize pre-pandemic.
Collaborating remotely can improve creativity in ways that many teams didn’t realize pre-pandemic.
Collecting and analyzing the right employee data can help leaders build more equitable workplaces.
Recommendation engines promise to revolutionize how customers buy and employees work.
In B2B, pandemic-driven cost initiatives should be guided by an intense focus on customer value.
Boards will need increased technology fluency to provide adequate oversight of AI risk management.
Despite advances in automation, good people and good techniques remain essential to manual work.
By better integrating human and device intelligence, we can foster collective intelligence.
Past pandemics changed the course of history, but our knowledge economy may limit the impact of COVID-19.
Leading through difficult times requires agility to leverage the turbulence around you.
Employers could use surveillance tools — with constraints — to keep workers safe and healthy.
Managers face a choice: use technology to recreate employees’ former office work lives, or craft a new strategy.
Focusing on better conversations can improve collaboration and unlock creative solutions to business problems.
The pandemic may bring sweeping changes to economic and workplace structures we take for granted.
The race to develop treatments and a vaccine for COVID-19 highlights the value of repurposing solutions.
Virtual work arrangements can erode relationships. Here’s what can go wrong and how to bolster connections.
Computer scientists typically lead AI development, but teams with diverse expertise can build better systems.
Assessments about China’s strengths in AI may be overblown.
Digital technologies have given rise to these new leadership imperatives.
Many organizations aren’t fully aware of or adequately minimizing the risks posed by social media.
Pharma’s existing model may be a liability in the race to develop drugs and vaccines to combat COVID-19.